Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CHRONIC PHASE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 329 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Khoury, H; Adkins, D; Brown, R; Pence, H; Vij, R; Goodnough, LT; Westervelt, P; Trinkaus, K; Lin, HS; DiPersio, J
      Low incidence of transplantation-related acute complications in patients with chronic myeloid leukemia undergoing allogeneic stem cell transplantation with a low-dose (550 cGy) total body irradiation conditioning regimen

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    2. Patterson, AE; Korngold, R
      Infusion of select leukemia-reactive TCR V beta(+) T cells provides graft-versus leukemia responses with minimization of graft-versus-host disease following murine hematopoietic stem cell transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    3. Van Etten, RA
      Pathogenesis and treatment of Ph+ leukemia: recent insights from mouse models

      CURRENT OPINION IN HEMATOLOGY
    4. Clark, RE; Christmas, SE
      BCR-ABL fusion peptides and cytotoxic T cells in chronic myeloid leukaemia

      LEUKEMIA & LYMPHOMA
    5. Kitzis, A; Brizard, F; Dascalescu, C; Chomel, JC; Guilhot, F; Brizard, A
      Persistence of transcriptionally silent BCR-ABL rearrangements in chronic myeloid leukemia patients in sustained complete cytogenetic remission

      LEUKEMIA & LYMPHOMA
    6. Vey, N; Balatzentko, G; LaFage, M; Sainty, D; Bouabdallah, R; Chabannon, C; Blaise, D; Gastaut, JA; Gabert, J
      Survey of early disapearance of BCR/ABL fusion transcript after allogeneicor autologous stem cell transplantation for chronic myelogenous leukemia

      LEUKEMIA & LYMPHOMA
    7. Lindauer, M; Fischer, T
      Interferon-alpha combined with cytarabine in chronic myelogenous leukemia - Clinical benefits

      LEUKEMIA & LYMPHOMA
    8. Mauro, MJ; Druker, BJ
      Chronic myelogenous leukemia

      CURRENT OPINION IN ONCOLOGY
    9. Plevier, CM; Mooy, JM; de Mheen, PJMV; Stouthard, MEA; Visser, MC; Grobbee, DE; Gunning-Schepers, LJ
      Persistent impaired emotional functioning in survivors of a myocardial infarction?

      QUALITY OF LIFE RESEARCH
    10. Mughal, TI; Goldman, JM
      Chronic myeloid leukaemia: STI 571 magnifies the therapeutic dilemma

      EUROPEAN JOURNAL OF CANCER
    11. O'Dwyer, ME; Druker, BJ
      Chronic myelogenous leukaemia - new therapeutic principles

      JOURNAL OF INTERNAL MEDICINE
    12. Kim, I; Park, S; Kim, BK; Chang, HM; Bang, SM; Byun, JH; Kim, DJ; Min, WS; Kim, HJ; Kim, CC
      Allogeneic bone marrow transplantation for chronic myeloid leukemia: a retrospective study of busulfan-cytoxan versus total body irradiation-cytoxan as preparative regimen in Koreans

      CLINICAL TRANSPLANTATION
    13. Brunstein, CG; McGlave, PB
      The biology and treatment of chronic myelogenous leukemia

      ONCOLOGY-NEW YORK
    14. Cai, Z; Lin, M; Wuchter, C; Ruppert, V; Dorken, B; Ludwig, WD; Karawajew, L
      Apoptotic response to homoharringtonine in human wt p53 leukemic cells is independent of reactive oxygen species generation and implicates Bax translocation, mitochondrial cytochrome c release and caspase activation

      LEUKEMIA
    15. Michallet, M; Bilger, K; Garban, F; Attal, M; Huyn, A; Blaise, D; Milpied, N; Moreau, P; Bordigoni, P; Kuentz, M; Sadoun, A; Cahn, JY; Socie, G; Thomas, X; Arnaud, P; Raus, N; Lheritier, V; Pigneux, A; Boiron, JM
      Allogeneic hematopoietic stem-cell transplantation after nonmyeloablative preparative regimens: Impact of pretransplantation and posttransplantation factors on outcome

      JOURNAL OF CLINICAL ONCOLOGY
    16. Ohnishi, K; Ino, T; Kishimoto, Y; Usui, N; Shimazaki, C; Ohtake, S; Taguchi, H; Kusumoto, S; Kuriyama, K; Hotta, T; Ohno, R
      Multicenter prospective study of interferon-alpha versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia: a preliminary analysis

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    17. Schots, R; Van Riet, I; Ben Othman, T; Trullemans, F; De Waele, M; Van Camp, B
      The impact of partial T cell depletion on overall transplant-related toxicity, graft function and survival after HLA-identical allogeneic bone marrowtransplantation in standard risk adult patients with leukemia

      BONE MARROW TRANSPLANTATION
    18. Lysak, D; Koza, V; Jindra, P; Vozobulova, V; Schutzova, M; Fiser, J; Cerna, K; Karas, M; Skopek, P; Svojgrova, M; Vokurka, S
      Allogeneic BMT in patients above 45 years of age: a single center experience

      BONE MARROW TRANSPLANTATION
    19. Thiele, J; Kvasnicka, HM; Beelen, DW; Welter, A; Schneider, S; Leder, LD; Schaefer, UW
      Reconstitution of the CD45RO(+) and CD20(+) lymphoid marrow population following allogeneic bone marrow transplantation for Ph+ CML

      BONE MARROW TRANSPLANTATION
    20. Thiele, J; Kvasnicka, HM; Beelen, DW; Leder, LD; Schaefer, UW
      Bone marrow engraftment: histopathology of hematopoietic reconstitution following allogeneic transplantation in CML patients

      HISTOLOGY AND HISTOPATHOLOGY
    21. Kalidas, MT; Kantarjian, H; Talpaz, M
      Chronic myelogenous leukemia

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    22. Zorn, E; Orsini, E; Wu, CJ; Stein, B; Chillemi, A; Canning, C; Alyea, EP; Soiffer, RJ; Ritz, J
      A CD4+T cell clone selected from a CML patient after donor lymphocyte infusion recognizes BCR-ABL breakpoint peptides but not tumor cells

      TRANSPLANTATION
    23. Talpaz, M
      Interferon-alfa-based treatment of chronic myeloid leukemia and implications of signal transduction inhibition

      SEMINARS IN HEMATOLOGY
    24. Goldman, J
      Implications of imatinib mesylate for hematopoietic stem cell transplantation

      SEMINARS IN HEMATOLOGY
    25. Appelbaum, FR
      Perspectives on the future of chronic myeloid leukemia treatment

      SEMINARS IN HEMATOLOGY
    26. Bornhauser, M; Kiehl, M; Siegert, W; Schetelig, J; Hertenstein, B; Martin, H; Schwerdtfeger, R; Sayer, HG; Runde, V; Kroger, N; Theuser, C; Ehninger, G
      Dose-reduced conditioning for allografting in 44 patients with chronic myeloid leukaemia: a retrospective analysis

      BRITISH JOURNAL OF HAEMATOLOGY
    27. Kvasnicka, HM; Thiele, J; Schmitt-Graeff, A; Diehl, V; Zankovich, R; Niederle, N; Leder, LD; Schaefer, HE
      Prognostic impact of bone marrow erythropoietic precursor cells and myelofibrosis at diagnosis of Ph1+ chronic myelogenous leukaemia - a multicentre study on 495 patients

      BRITISH JOURNAL OF HAEMATOLOGY
    28. Craddock, C; Szydlo, RM; Dazzi, F; Olavarria, E; Cwynarski, K; Yong, A; Brookes, P; de la Fuente, J; Kanfer, E; Apperley, JF; Goldman, JM
      Cytomegalovirus seropositivity adversely influences outcome after T-depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored graft-versus-host disease prophylaxis

      BRITISH JOURNAL OF HAEMATOLOGY
    29. Sanz, GF; Saavedra, S; Planelles, D; Senent, L; Cervera, J; Barragan, E; Jimenez, C; Larrea, L; Martin, G; Martinez, J; Jarque, I; Moscardo, F; Plume, G; Andreu, R; Regadera, AI; Garcia, I; Molla, S; Solves, P; de la Rubia, J; Bolufer, P; Benlloch, L; Soler, MA; Marty, ML; Sanz, MA
      Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies

      BLOOD
    30. Socie, G; Clift, RA; Blaise, D; Devergie, A; Ringden, O; Martin, PJ; Remberger, M; Deeg, HJ; Ruutu, T; Michallet, M; Sullivan, KM; Chevret, S
      Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies

      BLOOD
    31. Bonifazi, F; de Vivo, A; Rosti, G; Guilhot, F; Guilhot, J; Trabacchi, E; Hehlmann, R; Hochhaus, A; Shepherd, PCA; Steegmann, JL; Kluin-Nelemans, HC; Thaler, J; Simonsson, B; Louwagie, A; Reiffers, J; Mahon, FX; Montefusco, E; Alimena, G; Hasford, J; Richards, S; Saglio, G; Testoni, N; Martinelli, G; Tura, S; Baccarani, M
      Chronic myeloid leukemia and interferon-alpha: a study of complete cytogenetic responders

      BLOOD
    32. Zhao, RC; Jiang, YH; Verfaillie, CM
      A model of human p210(bcr/ABL)-mediated chronic myelogenous leukemia by transduction of primary normal human CD34(+) cells with a BCR/ABL-containing retroviral vector

      BLOOD
    33. Olavarria, E; Kanfer, E; Szydlo, R; Kaeda, J; Rezvani, K; Cwynarski, K; Pocock, C; Dazzi, F; Craddock, C; Apperley, JF; Cross, NCP; Goldman, JM
      Early detection of BCR-ABL transcripts by quantitative reverse transcriptase-polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia

      BLOOD
    34. Davies, SM; DeFor, TE; McGlave, PB; Miller, JS; Verfaillie, CM; Wagner, JE; Weisdorf, DJ
      Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors

      AMERICAN JOURNAL OF MEDICINE
    35. Drobyski, WR
      Evolving strategies to address adverse transplant outcomes associated withT cell depletion

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    36. Holyoake, TL; Horrocks, C; Thomas, T; Eaves, CJ; Eaves, AC
      Cell separation improves the sensitivity of detecting rare human normal and leukemic hematopoietic cells in vivo in NOD/SCID mice

      CYTOTHERAPY
    37. Zheng, C; Pisa, P; Stromberg, O; Blennow, E; Hansson, M
      Generation of dendritic cells from peripheral blood of patients at different stages of chronic myeloid leukemia

      MEDICAL ONCOLOGY
    38. Cortes, J; O'Brien, S
      A guide to the use of interferon-alpha in the management of chronic myelogenous leukaemia

      BIODRUGS
    39. Flowers, MED; Leisenring, W; Beach, K; Riddell, S; Radich, JP; Higano, CS; Rowley, SD; Chauncey, TR; Bensinger, WI; Sanders, JE; Anasetti, C; Storb, R; Wade, J; Appelbaum, FR; Martin, PJ
      Granulocyte colony-stimulating factor given to donors before apheresis does not prevent aplasia in patients treated with donor leukocyte infusion forrecurrent chronic myeloid leukemia after bone marrow transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    40. Rodriguez, J; Cortes, J; Talpaz, M; O'Brien, S; Smith, TL; Rios, MB; Kantarjian, H
      Serum beta-2 microglobulin levels are a significant prognostic factor in Philadelphia chromosome-positive chronic myelogenous leukemia

      CLINICAL CANCER RESEARCH
    41. Kabarowski, JHS; Witte, ON
      Consequences of BCR-ABL expression within the hematopoietic stem cell in chronic myeloid leukemia

      STEM CELLS
    42. Reiter, E; Rabitsch, W; Greinix, HT; Keil, F; Mitterbauer, G; Hinterberger, W; Haas, OA; Lechner, K; Kalhs, P
      Relapse of chronic myelogenous leukemia 12 years after allogeneic marrow transplantation: Successful second transplantation with allogeneic peripheral blood progenitor cells

      LEUKEMIA & LYMPHOMA
    43. Guinn, BA; Evely, RS; Walsh, V; Gilkes, AF; Burnett, AK; Mills, KI
      An in vivo and in vitro comparison of the effects of b2-a2 and b3-a2 p210BCR-ABL splice variants on murine 32D cells

      LEUKEMIA & LYMPHOMA
    44. Anasetti, C; Petersdorf, EW; Martin, PJ; Woolfrey, A; Hansen, JA
      Improving availability and safety of unrelated donor transplants

      CURRENT OPINION IN ONCOLOGY
    45. Perego, RA; Costantini, M; Cornacchini, G; Gargantini, L; Bianchi, C; Pungolino, E; Rovida, E; Morra, E
      The possible influences of B2A2 and B3A2 BCR/ABL protein structure on thrombopoiesis in chronic myeloid leukaemia

      EUROPEAN JOURNAL OF CANCER
    46. Hehlmann, R; Hochhaus, A; Berger, U; Reiter, A
      Current trends in the management of chronic myelogenous leukemia

      ANNALS OF HEMATOLOGY
    47. Ohnishi, K; Minami, S; Ueda, T; Nishimura, M; Tsubaki, K; Takemoto, Y; Takeshita, A; Sao, H; Kageyama, S; Ueda, R; Ohno, R
      Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    48. Sao, H; Kato, C; Kitaori, K; Adachi, T; Yano, K; Kobayashi, M; Kojima, H; Tanimoto, M; Hirabayashi, N; Minami, S; Yamada, H; Morishita, Y; Morishima, Y; Kodera, Y
      Effective and safe interferon treatment for Japanese patients with chronicmyelogenous leukemia relapse after bone marrow transplantation

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    49. Thiele, J; Kvasnicka, HM; Schmitt-Graeff, A
      Therapy-related changes of CD20(+) and CD45RO(+) lymphocyte subsets in chronic myeloid leukemia (CML): An immunohistochemical and morphometric study on sequential trephine biopsies of the bone marrow

      MODERN PATHOLOGY
    50. Talpaz, M; Berman, E; Clift, RA; Copelan, EA; Emanuel, PD; Erba, HP; Glenn, MJ; Greenberg, PL; Jones, RJ; O'Brien, S; Saba, HI; Schilder, R; Snyder, DS; Soiffer, RJ; Tallman, MS; Wetzler, M; Ravandi-Kashani, F; Kantarjian, H; Talpaz, M
      NCCN Practice Guidelines for chronic myelogenous leukemia

      ONCOLOGY-NEW YORK
    51. Hehlmann, R
      Trial of IFN or STl571 before proceeding to allografting for CML?

      LEUKEMIA
    52. Thiele, I; Kvasnicka, HM; Beelen, DW; Pilgram, B; Rose, A; Leder, LD; Schaefer, UW
      Erythropoietic reconstitution, macrophages and reticulin fibrosis in bone marrow specimens of CML patients following allogeneic transplantation

      LEUKEMIA
    53. Rombouts, WJC; Martens, ACM; Ploemacher, RE
      Identification of variables determining the engraftment potential of humanacute myeloid leukemia in the immunodeficient NOD/SCID human chimera model

      LEUKEMIA
    54. Olavarria, E; Parker, S; Craddock, C; Philpott, N; Tiniakou, M; Chase, A; Kanfer, E; Apperley, JF; Goldman, JM
      Collection of Ph-negative progenitor cells from interferon-responsive patients with chronic myeloid leukemia: effect of granulocyte-colony-stimulating factor mobilization

      HAEMATOLOGICA
    55. Martinelli, G; Montefusco, V; Testoni, N; Amabile, M; Saglio, G; Ottaviani, E; Terragna, C; Bonifazi, F; Rosti, G; Bandini, G; Tura, S
      Clinical value of quantitative long-term assessment of bcr-abl chimeric transcript in chronic myelogenous leukemia patients after allogeneic bone marrow transplantation

      HAEMATOLOGICA
    56. Carreras, E; Tomas, JF; Sanz, G; Iriondo, A; Boque, C; Lopez, J; Cabrera, R; Sureda, A; de Soria, VGG; Sierra, J; Sanz, MA; Torres, A
      Unrelated donor bone marrow transplantation as treatment for chronic myeloid leukemia: the Spanish experience

      HAEMATOLOGICA
    57. Bhatia, R; Munthe, HA; Williams, AD; Zhang, F; Forman, SJ; Slovak, ML
      Chronic myelogenous leukemia primitive hematopoietic progenitors demonstrate increased sensitivity to growth factor-induced proliferation and maturation

      EXPERIMENTAL HEMATOLOGY
    58. Corsetti, MT; Lerma, E; Dejana, A; Cavaliere, M; Figari, O; Vassallo, F; Abate, M; Luchetti, S; Piaggio, G; Parodi, C; Pira, GL; Manca, F; Carella, AM
      Cytogenetic response to autografting in chronic myelogenous leukemia correlates with the amount of BCR-ABL positive cells in the graft

      EXPERIMENTAL HEMATOLOGY
    59. Thiele, J; Kvasnicka, HM; Beelen, DW; Zirbes, TK; Jung, F; Reske, D; Leder, LD; Schaefer, UW
      Relevance and dynamics of myelofibrosis regarding hematopoietic reconstitution after allogeneic bone marrow transplantation in chronic myelogenous leukemia - a single center experience on 160 patients

      BONE MARROW TRANSPLANTATION
    60. McBride, NC; Cavenagh, JD; Newland, AC; Lillington, DM; Murrell, C; Kelsey, SM
      Autologous transplantation with Philadelphia-negative progenitor cells forpatients with chronic myeloid leukaemia (CML) failing to attain a cytogenetic response to alpha interferon

      BONE MARROW TRANSPLANTATION
    61. Brunstein, CG; Hirsch, BA; Miller, JS; McGlennen, RC; Verfaillie, CM; McGlave, PB; Weisdorf, DJ
      Non-leukemic autologous reconstitution after allogeneic bone marrow transplantation for Ph-positive chronic myelogenous leukemia: extended remission preceding eventual relapse

      BONE MARROW TRANSPLANTATION
    62. Copelan, EA; Penza, SL; Theil, KS; Elder, PJ; Bechtel, TP; Tighe, MB; Ezzone, SA; Scholl, MD; Belt, PS; Young, DC; Avalos, BR
      The influence of early transplantation, age, GVHD prevention regimen, and other factors on outcome of allogeneic transplantation for CML following BuCy

      BONE MARROW TRANSPLANTATION
    63. Schattenberg, A; Schaap, N; Preijers, F; van der Maazen, R; de Witte, T
      Outcome of T cell-depleted transplantation after conditioning with an intensified regimen in patients aged 50 years or more is comparable with that in younger patients

      BONE MARROW TRANSPLANTATION
    64. Oguma, N; Hyodo, H; Tanaka, H; Kimura, A
      Various response patterns of Ph ' cells to IFN-alpha in patients with chronic myelocytic leukemia

      EXPERIMENTAL ONCOLOGY
    65. Thiele, J; Kvasnicka, HM; Schmitt-Graeff, A; Schaefer, HE
      Histopathological and hematological findings in CML - a comparative immunohistochemical-morphometric and clinical study on bone marrow biopsies from 604 patients derived from two institutes of pathology (Cologne/Freiburg)

      PATHOLOGE
    66. Kamel, AM; Shaker, HM; GadAllah, FH; Hamza, MR; Mansour, O; El Hattab, OH; Moussa, HS
      A simple strategy for breakpoint fragment determination in chronic myeloidleukemia

      CANCER GENETICS AND CYTOGENETICS
    67. Hess, G; Reifenrath, C; Friedrich-Freksa, A; Boyer, V; Naumann, S; Schuch, B; Huber, C; Fischer, T; Decker, HJ
      Autologous transplantation of in vivo purged PBSC in CML: Comparison of FISH, cytogenetics, and PCR detection of Philadelphia chromosome in leukapheresis products

      CANCER GENETICS AND CYTOGENETICS
    68. Faderl, S; Kantarjian, HM; Talpaz, M; O'Brien, S
      New treatment approaches for chronic myelogenous leukemia

      SEMINARS IN ONCOLOGY
    69. Novitzky, N; Rubinstein, R; Hallett, JM; du Toit, CE; Thomas, VL
      Bone marrow transplantation depleted of T cells followed by repletion withincremental doses of donor lymphocytes for relapsing patients with chronicmyeloid leukemia - A therapeutic strategy

      TRANSPLANTATION
    70. Zamecnikova, A
      Chronic myelogenous leukemia as gene activation model in oncology - Minireview

      NEOPLASMA
    71. Kantarjian, HM; Giles, FJ; O'Brien, S
      Therapeutic choices in younger patients with chronic myelogenous leukemia

      CANCER
    72. Watari, K; Tojo, A; Nagamura-Inoue, T; Matsuoka, M; Irie, S; Tani, K; Yamada, Y; Asano, S
      Hyperfunction of neutrophils in a patient with BCR/ABL negative chronic myeloid leukemia - A case report with in vitro studies

      CANCER
    73. Cho, EK; Heo, DS; Seol, JG; Seo, EJ; Chi, HS; Kim, ES; Lee, YY; Kim, BK; Kim, NK
      Ontogeny of natural killer cells and T cells by analysis of BCR-ABL rearrangement from patients with chronic myelogenous leukaemia

      BRITISH JOURNAL OF HAEMATOLOGY
    74. Olavarria, E; Kanfer, E; Szydlo, R; O'Brien, S; Craddock, C; Apperley, J; Goldman, J
      High-dose busulphan alone as cytoreduction before allogeneic or autologousstem cell transplantation for chronic myeloid leukaemia: a single-centre experience

      BRITISH JOURNAL OF HAEMATOLOGY
    75. Dazzi, F; Szydlo, RM; Cross, NCP; Craddock, C; Kaeda, J; Kanfer, E; Cwynarski, K; Olavarria, E; Yong, A; Apperley, JF; Goldman, JM
      Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia

      BLOOD
    76. Dazzi, F; Szydlo, RM; Cross, NCP; Craddock, C; Kaeda, J; Kanfer, E; Cwynarski, K; Olavarria, E; Yong, A; Apperley, JF; Goldman, JM
      Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia

      BLOOD
    77. Hsieh, MH; Korngold, R
      Differential use of FasL- and perforin-mediated cytolytic mechanisms by T-cell subsets involved in graft-versus-myeloid leukemia responses

      BLOOD
    78. Craddock, C; Szydio, RM; Klein, JP; Dazzi, F; Olavarria, E; van Rhee, F; Pocock, C; Cwynarski, K; Apperley, JF; Goldman, JM
      Estimating leukemia-free survival after allografting for chronic myeloid leukemia: a new method that takes into account patients who relapse and are restored to complete remission

      BLOOD
    79. McGlave, PB; Shu, XO; Wen, WQ; Anasetti, C; Nadermanee, A; Champlin, R; Antin, JH; Kernan, NA; King, R; Weisdorf, DJ
      Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9years' experience of the National Marrow Donor Program

      BLOOD
    80. Brummendorf, TH; Holyoake, TL; Rufer, N; Barnett, MJ; Schulzer, M; Eaves, CJ; Eaves, AC; Lansdorp, PM
      Prognostic implications of differences in telomere length between normal and malignant cells from patients with chronic myeloid leukemia measured by flow cytometry

      BLOOD
    81. Honda, H; Ushijima, T; Wakazono, K; Oda, H; Tanaka, Y; Aizawa, S; Ishikawa, T; Yazaki, Y; Hirai, H
      Acquired loss of p53 induces blastic transformation in p210(bcr/abl)-expressing hematopoietic cells: a transgenic study for blast crisis of human CML

      BLOOD
    82. Sinclair, PB; Nacheva, EP; Leversha, M; Telford, N; Chang, J; Reid, A; Bench, A; Champion, K; Huntly, B; Green, AR
      Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia

      BLOOD
    83. Chomel, JC; Brizard, F; Veinstein, A; Rivet, J; Sadoun, A; Kitzis, A; Guilhot, F; Brizard, A
      Persistence of BCR-ABL genomic rearrangement in chronic myeloid leukemia patients in complete and sustained cytogenetic remission after interferon-alpha therapy or allogeneic bone marrow transplantation

      BLOOD
    84. Giralt, S; Szydio, R; Goldman, JM; Veum-Stone, J; Biggs, JC; Herzig, RH; Klein, JP; McGlave, PB; Schiller, G; Gale, RP; Rowlings, PA; Horowitz, MM
      Effect of short-term interferon therapy on the outcome of subsequent HLA-identical sibling bone marrow transplantation for chronic myelogenous leukemia: an analysis from the International Bone Marrow Transplant Registry

      BLOOD
    85. Verfuerth, S; Peggs, K; Vyas, P; Barnett, L; O'Reilly, RJ; Mackinnon, S
      Longitudinal monitoring of immune reconstitution by CDR3 size spectratyping after T-cell-depleted allogeneic bone marrow transplant and the effect ofdonor lymphocyte infusions on T-cell repertoire

      BLOOD
    86. Guglielmi, C; Arcese, W; Hermans, J; Bacigalupo, A; Bandini, G; Bunjes, D; Carreras, E; Devergie, A; Frassoni, F; Goldman, J; Gratwohl, A; Kolb, HJ; Iori, AP; Niederwieser, D; Prentice, HG; de Witte, E; Apperley, J
      Risk assessment in patients with Ph+ chronic myelogenous leukemia at firstrelapse after allogeneic stem cell transplant: an EBMT retrospective analysis

      BLOOD
    87. Stagno, F; Guglielmo, P; Consoli, U; Inghilterra, G; Giustolisi, GM; Palumbo, GA; Giustolisi, R
      In vitro apoptotic response of freshly isolated chronic myeloid leukemia cells to all-trans retinoic acid and cytosine arabinoside

      ACTA HAEMATOLOGICA
    88. Meissner, RD; Covas, DT; Dias, PMB; Job, F; Leite, M; Nardi, NB
      Analysis of mRNA transcripts in chronic myeloid leukemia patients

      GENETICS AND MOLECULAR BIOLOGY
    89. Verfaillie, CM; McIvor, RS; Zhao, RCH
      Gene therapy for chronic myelogenous leukemia

      MOLECULAR MEDICINE TODAY
    90. Sawyers, CL; Druker, B
      Tyrosine kinase inhibitors in chronic myeloid leukemia

      CANCER JOURNAL FROM SCIENTIFIC AMERICAN
    91. Skiera, D; Zeller, W; Zander, AR
      Graft engineering of G-CSF-mobilized allogeneic leukapheresis products by counterflow centrifugal elutriation after CD34 column adsorption

      JOURNAL OF HEMATOTHERAPY
    92. Fiegl, M; Mitterbauer, G; Weltermann, A; Pirc-Danoewinata, H; Jager, U
      Chronic myelogenous leukemia in chronic phase for 16 years: Ongoing hematological remission and late minor cytogenetic response under minimal interferon maintenance therapy

      LEUKEMIA & LYMPHOMA
    93. Spencer, A; Szydlo, R; Grand, FH; Goldman, JM; Melo, JV
      Abnormal patterns of immunoglobulin heavy chain gene DNA fingerprinting during chronic phase chronic myeloid leukemia

      LEUKEMIA & LYMPHOMA
    94. Pigneux, A; Mahon, FX; Reiffers, J
      Autologous peripheral blood stem cell transplantation for chronic myelocytic leukaemia, using unmanipulated grafts

      BAILLIERES CLINICAL HAEMATOLOGY
    95. Carella, AM; Cavaliere, M; Lerma, E; Corsetti, MT
      Autologous peripheral blood haematopoietic stem cell transplantation for chronic myelogenous leukaemia

      BAILLIERES CLINICAL HAEMATOLOGY
    96. Matsumoto, K; Morita, K; Takada, S; Sakura, T; Shiozaki, H; Murakami, H; Miyawaki, S
      A chronic myelogenous leukemia-like myeloproliferative disorder accompanied by T-cell lymphoblastic lymphoma with chromosome translocation t(8;13)(p11;q12): a Japanese case

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    97. Fujii, S; Shimizu, K; Fujimoto, K; Kiyokawa, T; Shimomura, T; Taniguchi, O; Kinoshita, M; Kawano, F
      Analysis of a chronic myelogenous leukemia patient vaccinated with leukemic dendritic cells following autologous peripheral blood stem cell transplantation

      JAPANESE JOURNAL OF CANCER RESEARCH
    98. Faderl, S; Kantarjian, HM; Talpaz, M
      Chronic myelogenous leukemia: Update on biology and treatment

      ONCOLOGY-NEW YORK
    99. Berman, E
      Chronic myelogenous leukemia: Update on biology and treatment - The Faderl/Kantarjian/Talpaz article reviewed

      ONCOLOGY-NEW YORK
    100. Guyotat, D; Wahbi, K; Viallet, A; Piselli, S; Campos, L
      Selection of BCR/ABL-negative stem cells from marrow or blood of patients with chronic myeloid leukemia

      LEUKEMIA


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/20 alle ore 04:50:21